X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

Is national security a game changer for European foreign investment reviews and M&A transactions?

Governments all over the world are continuing to take steps to strengthen their powers to intervene ...

Read More >

US Government Proposes to Lift Ban on Financing Nuclear Energy Projects Overseas

The United States has been struggling to compete with its peers in securing nuclear power plant cons...

Read More >

Speeding Up and Slowing Down Antitrust Reviews – How the Federal Antitrust Agencies Are Responding to the COVID-19 Crisis

Make no mistake, the antitrust laws remain in full effect. The leadership of the Antitrust Division...

Read More >

Offshore wind farms (OWF) – an update from Poland

With costs coming down, a pre-existing supply chain, and other sites being developed nearby, Poland ...

Read More >

Dear YouDig? Project Leadership - Find Your Quarterback and Win!

Dear YouDig? I am CEO of a mid-west  manufacturing company. At long last, those extremely tough tim...

Read More >

“Actually, I *Am* The Boss Of You” - An Interactive Approach To Employee Counseling

To many employees, being written up is perceived as another way of being told that someone is the bo...

Read More >